Posted on: 07 September, 2023
The latest Kolling Institute NEWS is out ... providing a snapshot of the wonderful research activity across our institute from our work into heart disease, pain, diabetes, cancer and musculoskeletal conditions. Check it out.
Read more
Category: Newsletters, Research Excellence
Posted on: 05 September, 2023
A valuable digital resource has been launched to help people with spinal cord injuries troubleshoot some of the complex health challenges that can arise after injury.
The Spinal Cord Injury Health Maintenance Tool, which includes a website, smartphone app and hardcopy booklets, has been designed to empower people to self-manage their health-related needs and maintain a high quality of li.....
Read more
Category: Musculoskeletal Research, Neuroscience and Pain Research, Research Excellence
Posted on: 31 August, 2023
Our researchers at the Kolling Institute are set to influence the delivery of osteoarthritis care across Australia following a significant funding announcement.
More than $1.4 million has been awarded to internationally recognised rheumatologist and researcher Professor David Hunter as part of the NHMRC Partnership Project Grants Scheme.
The scheme is designed to help researchers work di.....
Read more
Category: Musculoskeletal Research, Research Excellence
Posted on: 22 August, 2023
We would like to congratulate Kolling Institute researcher Amanda Purcell who has received a Juvenile Diabetes Research Foundation scholarship.
Amanda is part of our Renal Research Laboratory, working to improve treatment for those with diabetes and kidney disease.
She has been awarded a top-up scholarship aimed at supporting PhD students pursuing type 1 diabetes research in line with th.....
Read more
Category: Awards, Cardiovascular and Renal Research, Research Excellence
Posted on: 26 July, 2023
With a concerning rise in the number of people developing Type 2 diabetes, our researchers at the Kolling Institute are offering hope and an effective way forward to reduce the impact of the serious disease.
Type 2 diabetes is the fastest growing chronic disease in the world, and if the current trend continues, it’s anticipated close to three million Australians will have the disease by .....
Read more
Category: Cardiovascular and Renal Research, New Treatment, Research Excellence
Posted on: 24 July, 2023
Impressive new infrastructure at the Kolling Institute is set to drive progress with our research into cancer and neuroscience.
The equipment includes a digital spatial profiling system, which is regarded as one of the most exciting technological advances globally in the investigation of tissues.
The $525,000 instrument has been made possible following a LIEF grant through the Australian.....
Read more
Category: Funding support
Posted on: 18 July, 2023
The Kolling Institute hosted a special visit by the family of the late Bill Walsh who donated vital funds to establish a cancer laboratory within the Kolling.
His family, including his wife, daughters and grandchildren visited the lab to maintain their strong ties with the research team and meet with Academic Director Professor Jim Elliott.
Established in 1980, the Bill Walsh Cancer Rese.....
Read more
Category: Funding support, Research Excellence
Posted on: 17 July, 2023
With the number of people living with low back pain escalating sharply, researchers are turning to widely-accessible technology to reduce the impact of the disabling condition.
The team from the University of Sydney and the Kolling Institute has launched a study measuring the effectiveness of a mobile health program which offers self-management strategies via text messages.
Study lead Pr.....
Read more
Category: Musculoskeletal Research, New Treatment, Research Excellence
Posted on: 14 July, 2023
The expertise across Australia’s space medicine community was showcased during a special event co-ordinated by the Kolling Institute and the Australasian Society of Aerospace Medicine.
Staged over two days, the colloquium involved national and international experts including representatives from the Australian Space Agency, the CSIRO, Boeing and the Australian Antarctic Program.
Presente.....
Read more
Category: New Treatment, Research Excellence
Posted on: 10 July, 2023
Check out our Kolling Institute Year in Review 2022 celebrating our research success. It highlights our world-leading translational research and our impact across our priority research areas. Click on the link here.
Read more
Category: Cardiovascular and Renal Research, Musculoskeletal Research, Neuroscience and Pain Research